JELMYTO is a Kit in the Human Prescription Drug category. It is labeled and distributed by Urogen Pharma, Inc.. The primary component is .
Product ID | 72493-103_9e071934-f31d-474c-a3bd-94476540f0f2 |
NDC | 72493-103 |
Product Type | Human Prescription Drug |
Proprietary Name | JELMYTO |
Generic Name | Mitomycin |
Dosage Form | Kit |
Marketing Start Date | 2020-05-01 |
Marketing Category | NDA / NDA |
Application Number | NDA211728 |
Labeler Name | UroGen Pharma, Inc. |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-05-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA211728 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2020-05-01 |
NDC | Brand Name | Generic Name |
---|---|---|
69605-103 | JELMYTO | mitomycin |
72493-103 | JELMYTO | JELMYTO |
0143-9135 | Mitomycin | Mitomycin |
0143-9136 | Mitomycin | Mitomycin |
0143-9279 | Mitomycin | Mitomycin |
0143-9280 | Mitomycin | Mitomycin |
16729-108 | Mitomycin | Mitomycin |
16729-115 | Mitomycin | Mitomycin |
16729-116 | Mitomycin | Mitomycin |
16729-246 | Mitomycin | Mitomycin |
16729-247 | Mitomycin | Mitomycin |
16729-248 | Mitomycin | Mitomycin |
67457-518 | Mitomycin | Mitomycin |
67457-519 | Mitomycin | Mitomycin |
67457-520 | Mitomycin | Mitomycin |
67457-995 | Mitomycin | Mitomycin |
67457-996 | Mitomycin | Mitomycin |
67457-997 | Mitomycin | Mitomycin |
68001-389 | Mitomycin | Mitomycin |
68001-390 | Mitomycin | Mitomycin |
68001-391 | Mitomycin | Mitomycin |
68083-483 | MITOMYCIN | MITOMYCIN |
68083-484 | MITOMYCIN | MITOMYCIN |
68083-502 | MITOMYCIN | MITOMYCIN |
71288-137 | MITOMYCIN | MITOMYCIN |
71288-138 | MITOMYCIN | MITOMYCIN |
49771-002 | Mitosol | mitomycin |
69448-001 | MUTAMYCIN | Mitomycin |
69448-002 | MUTAMYCIN | Mitomycin |
69448-003 | MUTAMYCIN | Mitomycin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
JELMYTO 88204510 not registered Live/Pending |
UROGEN PHARMA LTD. 2018-11-25 |